A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2007
03/28/2007	EP1765869A1 Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication
03/28/2007	EP1765821A2 Gram-positive carbapenem antibacterials and processes for their preparation
03/28/2007	EP1765755A1 Regulators of bacterial signalling pathways
03/28/2007	EP1765398A2 Human antibodies interacting with hiv gp41
03/28/2007	EP1765385A1 Sustained release vaccine composition
03/28/2007	EP1765383A1 Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections
03/28/2007	EP1765382A1 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides
03/28/2007	EP1765370A1 Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids
03/28/2007	EP1765360A2 Anti-viral uses of borinic acid complexes
03/28/2007	EP1765341A2 Methods of treating cellular proliferative disease using naphthalimide and parp-1 inhibitors
03/28/2007	EP1765337A1 Combination of anti-hiv reverse transcriptase and protease inhibitors
03/28/2007	EP1765336A2 Angiogenesis inhibitors
03/28/2007	EP1765330A2 Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
03/28/2007	EP1765321A1 Antimicrobial compositions and methods of use thereof
03/28/2007	EP1765318A2 Medium chain fatty acids applicable as anti-microbial agents
03/28/2007	EP1765313A2 Compounds for immunopotentiation
03/28/2007	EP1765288A1 Methods of treatment of endobronchial infections
03/28/2007	EP1474441B1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
03/28/2007	EP1416958B1 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
03/28/2007	EP1414470B1 Micronutrient phosphates as dietary and health supplements
03/28/2007	EP1292298B1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
03/28/2007	EP1255449B1 Nutritional formulation containing prebiotic substances
03/28/2007	EP1254944B1 Dry compositions containing hydrophobic amino acid
03/28/2007	EP1233761B1 Osmotic dosage form comprising first and second coats
03/28/2007	EP1229933B1 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
03/28/2007	EP1228071B1 Pharmaceutically active isoindoline derivatives
03/28/2007	EP1064947B1 In ovo vaccination of marek's disease virus type 1
03/28/2007	CN1938311A Macrocyclic compounds as inhibitors of viral replication
03/28/2007	CN1938307A 9-substituted 8-oxoadenine compound
03/28/2007	CN1938306A Crystalline forms of 5, 11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one
03/28/2007	CN1938304A Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
03/28/2007	CN1938273A Tetrahydrocarbazoles and derivatives
03/28/2007	CN1938041A Influenza virus-infection inhibitor
03/28/2007	CN1938017A Therapeutic combinations
03/28/2007	CN1935833A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
03/28/2007	CN1935821A Antibacterial compound and its use
03/28/2007	CN1935818A Adefovir dipivoxil novel crystallinestate, crystalline state composition, and itspreparing method and use
03/28/2007	CN1935817A New acyclic nucleoside phosphate ester and its pharmaceutical use
03/28/2007	CN1935779A N-(N-benzoyl-phenylalanyl)-phenylalanine dipeptide derivative, and its preparing method and use
03/28/2007	CN1935762A Pharmaceutical use of ent-eudesmane alcohol type sesquiterpene for inhibiting hepatitis virus
03/28/2007	CN1935262A Use of red Nocardia cyto skeleton for preparing anti human papillomavirus medicine
03/28/2007	CN1935260A Human antibodies that bind human tnfalpha
03/28/2007	CN1935258A West nile vaccine
03/28/2007	CN1935256A Technology for preparing compound human inter feron spray agent capable of preventing polytypic influenza
03/28/2007	CN1935254A Neuregulin for treating cardio vascular disease, and its method and composition
03/28/2007	CN1935240A Quality control method for Chinese medicine composition preparation for treating children's cold
03/28/2007	CN1935213A Use of total saponinof sapindusmukeossi for preparing clinical medicine
03/28/2007	CN1935209A Chinese for treating hand-foot tinea
03/28/2007	CN1935206A Chinese medicine composition for treating herpes zoster
03/28/2007	CN1935174A Animal medicament with expelling toxin bycooling, calming liver to brighten vision and its preparing method
03/28/2007	CN1935165A Moringaceae tablet and its producing method
03/28/2007	CN1935161A Ear antibacterial agent
03/28/2007	CN1935156A Remedy
03/28/2007	CN1935155A Remedy
03/28/2007	CN1935145A Pharmaceutical use of sophora alkaloids tanate for preventing and treating skin and mucosa infection
03/28/2007	CN1935142A Slow-release capsule using noinclude, loratadine and pseudoephedrinesulfate as effective component, and its preparing method
03/28/2007	CN1935141A Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
03/28/2007	CN1935133A Human leucocyte antigen DR4 subtype protein agonist
03/28/2007	CN1935131A Pharmaceutical use of 1 beta-hydroxy ilexolic acid for inhibiting hepatitis virus
03/28/2007	CN1935122A Methylene blue lyophilized preparation, and its preparing method and use
03/28/2007	CN1934945A Use of imazalil for sunitary product and sterilizer product and its use method
03/28/2007	CN1307308C Nucleotide specific for Escherichia coli 085-type O-antigen
03/28/2007	CN1307307C Nucleotide specific for Shigella bogdii B14-type O-antigen
03/28/2007	CN1307306C Nucleotide specific for Escherichia coli 011-type O-antigen
03/28/2007	CN1307196C Modified CpG oligodeoxynucleotide with improved immunoregulatory function
03/28/2007	CN1307194C Macrolides
03/28/2007	CN1307177C Synthesis and purification of valacyclovir
03/28/2007	CN1307176C Novel alkoxypyridine-derivatives
03/28/2007	CN1307163C Imidazole aromatic alcohol derivatives and preparation and use thereof
03/28/2007	CN1306962C Canine distemper virus separated in korea and recombinant vaccine therefrom
03/28/2007	CN1306961C Preparation of tetravalent wheel shaped virus inactivated vaccine and application
03/28/2007	CN1306960C Curtail hemagglutinin vaccine for preventing influenza virus and its preparing method
03/28/2007	CN1306959C Process for preparing subunit vaccine of reovirus antigen for grass carp
03/28/2007	CN1306958C Glycoconjugate vaccines for use in immune-compromised populations
03/28/2007	CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/28/2007	CN1306936C Eye drop of tobramycin and sodium hyaluronate and its prepn process
03/28/2007	CN1306930C Soft antiviral capsule and its prepn
03/28/2007	CN1306919C Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
03/27/2007	US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis
03/27/2007	US7196192 28-epirapalogs
03/27/2007	US7196118 Amidino compounds useful as nitric oxide synthase inhibitors
03/27/2007	US7196111 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
03/27/2007	US7196093 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant
03/27/2007	US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents
03/27/2007	US7196086 Substituted dihydroquinazolines
03/27/2007	US7196085 Phthalazinone derivatives
03/27/2007	US7196084 Cdc25 phosphatase inhibitors
03/27/2007	US7196080 Respiratory system disordeers; chronic obstructive pulminary disease
03/27/2007	US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome
03/27/2007	US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders
03/27/2007	US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
03/27/2007	US7195769 Bioavailability
03/27/2007	US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/27/2007	CA2278842C Use of peroxygen compounds in the control of hairy wart disease
03/27/2007	CA2219651C Antifungal composition
03/27/2007	CA2200582C Dna encoding human papillomavirus type 6a
03/22/2007	WO2007033175A1 Indolobenzazepine hcv ns5b inhibitors
03/22/2007	WO2007033032A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
03/22/2007	WO2007032794A2 Inhibition of viral gene expression using small interfering rna
03/22/2007	WO2007032466A1 Heterocyclic compound, and production process and use thereof

1 ... 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 ... 1798